Paper882199
A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow.
Donker AJ and 3 others. Neth J Med, 1977. Cited by 245 papers, by iCite.
Cite this record
ConductScience Library. A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Papers, record 882199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/882199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glomerular Filtration Rate | Major topic |
| Iodine Radioisotopes | Major topic |
| Kidney | Major topic |
| Humans | |
| Iodohippuric Acid | |
| Iothalamic Acid | |
| Kidney Diseases | |
| Kidney Function Tests | |
| Regional Blood Flow |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 245 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926819 | Renal Blood Flow as Marker for Disease Progression in ADPKD. | Kidney Int Rep | 2026 | https://conductscience.org/library/papers/42926819 | PubMed |
| 42733501 | Combining Cystatin C and Creatinine Increases eGFR Slope Accuracy in ADPKD. | Kidney Int Rep | 2026 | https://conductscience.org/library/papers/42733501 | PubMed |
| 41104261 | Comparison of radioactive and non-radioactive iothalamate and hippuran to assess kidney function. | Clin Kidney J | 2025 | https://conductscience.org/library/papers/41104261 | PubMed |
| 28118402 | Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial. | PLoS One | 2017 | https://conductscience.org/library/papers/28118402 | PubMed |
| 27339446 | Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients. | Clin Exp Nephrol | 2017 | https://conductscience.org/library/papers/27339446 | PubMed |
| 26162576 | Feasibility of measuring renal blood flow by phase-contrast magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease. | Eur Radiol | 2016 | https://conductscience.org/library/papers/26162576 | PubMed |
| 26123828 | Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction. | Clin Res Cardiol | 2016 | https://conductscience.org/library/papers/26123828 | PubMed |
| 24993447 | Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. | Clin J Am Soc Nephrol | 2014 | https://conductscience.org/library/papers/24993447 | PubMed |
| 23578944 | Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. | J Am Soc Nephrol | 2013 | https://conductscience.org/library/papers/23578944 | PubMed |
| 20930090 | Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. | Clin J Am Soc Nephrol | 2011 | https://conductscience.org/library/papers/20930090 | PubMed |
| 20413443 | Early renal abnormalities in autosomal dominant polycystic kidney disease. | Clin J Am Soc Nephrol | 2010 | https://conductscience.org/library/papers/20413443 | PubMed |
| 20299365 | Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. | Clin J Am Soc Nephrol | 2010 | https://conductscience.org/library/papers/20299365 | PubMed |
| 18979056 | Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. | Clin Res Cardiol | 2009 | https://conductscience.org/library/papers/18979056 | PubMed |
| 18650405 | Feasibility and impact of the measurement of extracellular fluid volume simultaneous with GFR by 125I-iothalamate. | Clin J Am Soc Nephrol | 2008 | https://conductscience.org/library/papers/18650405 | PubMed |
| 8110878 | Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood. | Ann Hematol | 1994 | https://conductscience.org/library/papers/8110878 | PubMed |
| 7498230 | Iodine-131 Hippuran for the estimation of renal plasma flow: requirements for radiochemical purity. | Eur J Nucl Med | 1995 | https://conductscience.org/library/papers/7498230 | PubMed |
| 7201356 | Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7201356 | PubMed |
| 6537801 | Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6537801 | PubMed |
| 6325198 | Reversible diminished renal 99mTc-DMSA uptake during converting-enzyme inhibition in a patient with renal artery stenosis. | Eur J Nucl Med | 1984 | https://conductscience.org/library/papers/6325198 | PubMed |
| 6096147 | Is the relative 99mTc-DMSA clearance a useful marker of proximal tubular dysfunction? | Eur J Nucl Med | 1984 | https://conductscience.org/library/papers/6096147 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/882199
GET https://conductscience.org/api/papers/v1/882199/cited_by?page=2